The stroke prevention in atrial fibrillation III study: Rationale, design, and patient features

Journal of Stroke and Cerebrovascular Diseases

Volumn 6, Issue 5, 1997, Pages 341-353

  Stroke Prevention in Atrial Fibrillation Investigators, ^a  

^a Stat and Epidemiol Res Corp   (United States)

Author keywords

Anticoagulation; Aspirin; Atrial fibrillation; Cerebrovascular disease; Embolism

Indexed keywords

EID: 0001252030     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3057(97)80217-0     Document Type: Article

References (53)

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
2. Albers G.W. Atrial fibrillation and stroke: Three new studies, three remaining question. Arch Intern Med 154 (1994) 1443-1448
3. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation is an independent risk factor for stroke: The Framingham Study. Stroke 22 (1991) 983-988
4. EAFT Study Group. European Atrial Fibrillation Trial: Secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and recent transient ischemic attack or minor ischemic stroke. Lancet 342 (1993) 1255-1262
5. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Stroke Prevention in Atrial Fibrillation II Study. Lancet 343 (1994) 687-691
6. Stroke Prevention in Atrial Fibrillation Investigators. The Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 84 (1991) 527-539
7. Petersen P., and Boysen G. Prevention of stroke in atrial fibrillation. N Engl J Med 323 (1990) 482
8. Hart R.G., and Halperin J.L. Atrial fibrillation and stroke: Revisiting the dilemmas. Stroke 25 (1994) 1337-1341
9. Laupacis A., Albers G., Dunn M., and Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest 102 (1992) 426S-433S
10. Matchar D. Guidelines for medical treatment for stroke prevention. Ann Intern Med 121 (1994) 41-53
11. Barnett H.J.M., Eliasziw M., and Meldrum H. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 332 (1995) 238-248
12. Feinberg W.M., Blackshear J.L., Laupacis A., Kronmal R., and Hart R.G. Prevalence, age distribution and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155 (1995) 469-473
13. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. I: clinical features in patients at risk. Ann Intern Med 116 (1992) 1-5
14. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. II: echocardiographic features in patients at risk. Ann Intern Med 116 (1992) 6-12
15. Stroke Prevention in Atrial Fibrillation Investigators. A differential effect of aspirin for the prevention of stroke in atrial fibrillation. J Stroke Cerebrovasc Dis 3 (1993) 181-188
16. Stroke Prevention in Atrial Fibrillation Investigators. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study. J Stroke Cerebrovasc Dis 5 (1995) 147-157
17. Miller V.T., Rothrock J.F., Pearce L.A., Feinberg W.M., Hart R.G., and Anderson D.C. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Neurology 43 (1993) 32-36
18. Miller V.T., Pearce L.A., Feinberg W.M., Rothrock J.F., Anderson D.C., and Hart R.G. Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Neurology 46 (1996) 238-240
19. Landefeld C.S., and Beyth R.J. Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention. Am J Med 95 (1993) 315-328
20. Gottlieb L.K., and Salem-Schatz S. Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice. Arch Intern Med 154 (1994) 1945-1953
21. Mathiesen T., Benediktsdottir K., Johnsson H., Lindquist M., and von Holst H. Intracranial traumatic and nontraumatic hemorrhagic complications of warfarin treatment. Acta Neurol Scand 91 (1995) 208-214
22. Gitter M.J., Jaeger T.M., Petterson T.M., Gersh B.J., and Silverstein M.D. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester, Minnesota. Mayo Clin Proc 70 (1995) 725-733
23. [letter]. Connolly S for the Atrial Fibrillation Investigators. Stroke prevention in Atrial Fibrillation II study. Lancet 343 (1994) 1509
24. Hart R.G., Boop B.S., and Anderson D.C. Oral anticoagulants and intracranial hemorrhage: facts and hypotheses. Stroke 26 (1995) 1471-1477
25. Stroke Prevention in Atrial Fibrillation Investigators. Committee on Echocardiography. Transesophageal echocardiography in nonvalvular atrial fibrillation: standards for acquisition and interpretation. J Am Soc Echocardiogr 9 (1996) 556-566
26. Poller L., McKernan A., Thomson J.M., Elstein M., Hirsch P.J., and Jones J.B. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. BMJ 295 (1987) 1309-1312
27. Bern M.M., Lokich J.J., Wallach S.R., Bothe A., Benotti P.N., Arkin C.F., Greco F.A., Huberman M., and Moore C. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized clinical trial. Ann Intern Med 112 (1990) 423-428
28. Fordyce M.J.F., Baker A.S., and Staddon G.E. Efficacy of fixed mini-dose warfarin prophylaxis in total hip replacement. BMJ 303 (1991) 219-220
29. Stein B., Fuster V., Halperin J.L., and Chesebro J.H. Antithrombotic risk in cardiac disease: an emerging approach based on pathogenesis and risk. Circulation 80 (1989) 1501-1513
30. Turpie A., Gent M., Laupacis A., Littour Y., Gunstensen J., Basile F., Klimek M., and Hirsch J. A comparison of aspirin with placebo in patients treated with warfarin and heart valve replacement. N Engl J Med 329 (1993) 524-529
31. Chesebro J.H., Fuster V., Elveback L.R., McGoon D.C., Pluth J.R., Puga F.J., Wallace R.B., Danielson G.K., Orszulak T.A., Piehler J.M., and Schaff H.V. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 51 (1983) 1537-1541
32. Meade T.W., Wilkes H.C., Stirling Y., Brennan P.J., Kelleher C., and Browne W. Randomized controlled trial of low-dose warfarin in the primary prevention of ischemic heart disease in men at high risk: design and pilot study. Eur Heart J 9 (1988) 836-843
33. Prichard P.J., Kitchingman G.K., Walt R.P., Daneshund T.K., and Hawkey C.J. Human gastromucosal bleeding induced by low dose aspirin, but not warfarin. BMJ 298 (1989) 496
34. Hawthorne A.B., Mahida Y.R., Cole A.T., and Hawkey C.J. Aspirin-induced gastric mucosal damage: prevention by enteric coating and relation to prostaglandins synthesis. Br J Clin Pharmacol 32 (1991) 77-83
35. Thompson S.G., Kienast J., Pyke S.D.M., Haverkate F., and Van de Loo J.C.W. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332 (1995) 635-641
36. Kistler J.P., Singer D.E., Millenson M.M., Bauer K.A., Gress D.R., and Barzegar S. Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation. Stroke 24 (1993) 1360-1365
37. Bussey J.I., Force R.W., Bianco T.M., and Leonard A.D. Reliance on prothrombin time ratios causes significant errors in anticoagulant therapy. Arch Intern Med 152 (1992) 278-282
38. Landefeld C.B., Anderson P.A., Goodnough L.T., Moir T.W., Hom D.L., Rosenblatt M.W., and Goldman L. The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy. J Clin Epidemiol 42 (1989) 711-718
39. Kannell W.B., Abbott R.D., Savage D.D., and McNamara P. Epidemiologic features of chronic atrial fibrillation: The Framingham Study. N Engl J Med 306 (1982) 1018-1022
40. Feinberg WM, Kronmal RA, Newman A, et al. Thromboembolic risk factors in an elderly population, with artial fibrilation: The Cardiovascualr Health Study. Submitted for publication.
41. Stoddard M.F., Dawkins P.R., Prince C.R., and Ammash N.M. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 25 (1995) 452-459
42. Brown J., and Sadler D.B. Left atrial thrombi in nonrheumatic atrial fibrillation: assessment of prevalence by transesophageal echocardiography. Int J Card Imaging 9 (1993) 65-72
43. Vaziri S.M., Larson M.G., Lauer M.S., Benjamin E.J., and Levy D. Influence of blood pressure on left atrial size. The Framingham Study. Hypertension 25 (1995) 1155-1160
44. Flegel K.M., and Harley J. Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation. Stroke 20 (1989) 1000-1004
45. Moulton A.W., Singer D.E., and Haas J.S. Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. Am J Med 91 (1991) 156-161
46. [suppl 1, abstr]. Chan K.L. Transesophageal echocardiographic risk factors for stroke are related to gender and age: observations from the SPAF III Study. Circulation 92 (1995) I-283
47. [suppl 1, abstr]. Asinger R.W., and Dick C.D. Clinical and transthoracic echo predictors of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation. Circulation 92 (1995) I-284
48. Man-Son-Hing M., Laupacis A., O'Connor A., and Wells G. Warfarin for atrial fibrillation: the patient's perspective. Arch Intern Med 156 (1996) 1841-1848
49. Flegel K.M., Hutchinson T.A., Gromme P.A., and Tousignant P. Factors relevant to preventing embolic stroke in patients with nonrheumatic atrial fibrillation. J Clin Epidemiol 44 (1991) 551-560
50. Hurlen M., Erikssen J., Smith P., Arnesen H., and Rollag A. Comparisons of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3,166 outpatients. J Intern Med 236 (1994) 299-304
51. Goodman S.G., Langer A., Durica S.S., Raskols G.E., Comys P.C., Gray R.J., et al. Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Am J Cardiol 74 (1994) 657-661
52. Meade T.W., Roderick P.J., Brennan P.J., Wilkes H.C., and Kelleher C.C. Extracranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation. Thromb Haemostas 68 (1992) 1-6
53. European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 333 (1995) 5-10